Blockchain Registration Transaction Record
Molecular Precision Targets Blind Spot in Heart Disease Detection
Cardio Diagnostics Holdings (CDIO) addresses a blind spot in coronary heart disease detection with epigenetic and genetic tests, improving sensitivity over traditional risk calculators.
This news matters because coronary heart disease is the leading cause of death in the US, yet current diagnostic tools miss half of cases. Cardio Diagnostics' epigenetic and genetic tests could revolutionize early detection, potentially saving lives by identifying at-risk individuals who are currently overlooked. For patients and healthcare providers, this means a more accurate, personalized approach to preventing heart attacks.
| Blockchain | Details |
|---|---|
| Contract Address | 0xeA2912a8DA1CD48401b10cB283585874d98098F4 |
| Transaction ID | 0xe7e5118594bf7a7048b4366dde2c3049eaed2a2a7ec88c9c797e42244d6bc011 |
| Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
| Chain | polygon-main |
| NewsRamp Digital Fingerprint | yarnFKPi-7ee3df6a72f272bc72e2f06c8568162b |